US Vaccine Recommendations Shifted to Mirror Denmark's, but Forget the Social Safety Net
In a move that has left many health experts and parents bewildered, the US Department of Health and Human Services (HHS) has revised its childhood vaccine schedule to align with Denmark's recommendations. The updated guidelines recommend fewer vaccines for children, including those against polio, chickenpox, and HPV.
While the shift may seem minor, it reflects a broader misconception that has long been a talking point in anti-vaccine campaigns: if it works in Europe, it must work here too. However, health officials warn that such an assumption is a major fallacy. European countries differ significantly from the US in terms of demographics, healthcare systems, social safety nets, and public health infrastructure – all factors that shape policy choices.
Josh Michaud, associate director of global health and public policy at KFF, notes that relying on guidelines developed elsewhere risks overlooking local conditions and realities that matter for effective public health policy. "The US has its own scientific institutions and experts who are capable of reviewing evidence and developing guidelines specific to the country," he said.
But there's another factor at play: the selective use of European comparisons. While Denmark's vaccine recommendations are being touted as a model, many other European countries have universal healthcare coverage, stronger social welfare programs, and stricter gun laws than the US. Yet these policies are rarely cited as models by US officials.
In fact, experts across peer countries generally agree on the underlying science of vaccine safety and efficacy. The issue lies in how that data is applied within each country's context and population.
Jens Lundgren, an infectious disease specialist at Copenhagen University Hospital, agrees. "Vaccine schedules should be based on a population's needs," he said. "For example, meningococcal diseases are not really a public health problem in Denmark. We feel that there are other vaccines that should be higher on the list at the moment."
The American Academy of Pediatrics (AAP) has expressed strong opposition to the revised guidelines, calling them "dangerous and unnecessary." Dr. Andrew Racine, AAP's president, noted that the US is a unique country with its own population, public health infrastructure, and disease risk.
The shift in vaccine recommendations raises concerns about confusion among parents and potential reductions in vaccination rates, leading to increased cases of preventable diseases. As Michaud pointed out, "Reclassifying vaccines for six diseases from routine recommendations to 'shared clinical decision-making' adds complexity for both providers and parents."
In a move that has left many health experts and parents bewildered, the US Department of Health and Human Services (HHS) has revised its childhood vaccine schedule to align with Denmark's recommendations. The updated guidelines recommend fewer vaccines for children, including those against polio, chickenpox, and HPV.
While the shift may seem minor, it reflects a broader misconception that has long been a talking point in anti-vaccine campaigns: if it works in Europe, it must work here too. However, health officials warn that such an assumption is a major fallacy. European countries differ significantly from the US in terms of demographics, healthcare systems, social safety nets, and public health infrastructure – all factors that shape policy choices.
Josh Michaud, associate director of global health and public policy at KFF, notes that relying on guidelines developed elsewhere risks overlooking local conditions and realities that matter for effective public health policy. "The US has its own scientific institutions and experts who are capable of reviewing evidence and developing guidelines specific to the country," he said.
But there's another factor at play: the selective use of European comparisons. While Denmark's vaccine recommendations are being touted as a model, many other European countries have universal healthcare coverage, stronger social welfare programs, and stricter gun laws than the US. Yet these policies are rarely cited as models by US officials.
In fact, experts across peer countries generally agree on the underlying science of vaccine safety and efficacy. The issue lies in how that data is applied within each country's context and population.
Jens Lundgren, an infectious disease specialist at Copenhagen University Hospital, agrees. "Vaccine schedules should be based on a population's needs," he said. "For example, meningococcal diseases are not really a public health problem in Denmark. We feel that there are other vaccines that should be higher on the list at the moment."
The American Academy of Pediatrics (AAP) has expressed strong opposition to the revised guidelines, calling them "dangerous and unnecessary." Dr. Andrew Racine, AAP's president, noted that the US is a unique country with its own population, public health infrastructure, and disease risk.
The shift in vaccine recommendations raises concerns about confusion among parents and potential reductions in vaccination rates, leading to increased cases of preventable diseases. As Michaud pointed out, "Reclassifying vaccines for six diseases from routine recommendations to 'shared clinical decision-making' adds complexity for both providers and parents."